Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
Summary
SAN FRANCISCO, April 21, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ('Olema” or 'Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutica...
Description
SAN FRANCISCO, April 21, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ('Olema” or 'Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutica...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source